vimarsana.com

Page 37 - டெல்ஹி துணை தலைமை அமைச்சர் மனிஷ் சிசோடியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delhi asks Centre to disclose data of vaccines supplied to states

Delhi asks Centre to disclose data of vaccines supplied to states Currently, Delhi has a vaccine stock of four days for those aged 45 years and above, he said, adding that for the 18-44 age group, the city will run out of the stock in three days PTI | May 17, 2021 | Updated 18:20 IST Sisodia urged the Centre to make the data of allocation of vaccines to the states public Delhi Deputy Chief Minister Manish Sisodia urged the Centre on Monday to make the data on vaccines supplied by it to the states public and sought 3.82 lakh doses of the vaccines for people aged 18-44 years in the city. Currently, Delhi has a vaccine stock of four days for those aged 45 years and above, he said, adding that for the 18-44 age group, the city will run out of the stock in three days.

Centre should make data on vaccine allocation to states public: Sisodia

Centre should make data on vaccine allocation to states public: Sisodia SECTIONS Last Updated: May 17, 2021, 05:47 PM IST Share Synopsis The Centre has written to us, saying we will get 3.83 lakh doses for the 45-plus age group but we will not get vaccines for the 18-44 age group in May, the Aam Aadmi Party (AAP) leader said. PTI Sisodia urged the Centre to make the data of allocation of vaccines to the states public. Delhi Deputy Chief Minister Manish Sisodia urged the Centre on Monday to make the data on vaccines supplied by it to the states public and sought 3.82 lakh doses of the vaccines for people aged 18-44 years in the city. Currently, Delhi has a vaccine stock of four days for those aged 45 years and above, he said, adding that for the 18-44 age group, the city will run out of the stock in three days.

Delhi seeks 3 82 lakh doses of vaccines for 18-44 age group, urges Centre to make data on vaccine allocation public

Delhi govt welcomes Centre s decision to invite other firms to produce Covaxin

Rare blood clot disorder among people who received J&J vaccine Amid reports of vaccine shortage coming from different parts of the country, the Centre and Hyderabad-based Bharat Biotech on Thursday exppressed their willingness to invite other companies to produce Covaxin in a bid to ramp up vaccine production in the country. Welcoming the Centre s decision, Delhi Deputy Chief Minister Manish Sisodia tweeted, We are very glad that Central government has agreed to allow other companies to manufacture Covaxin. We sincerely hope they will consider our other suggestion of importing vaccines as One Nation and not as different states seriously as well.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.